Project description
Medical innovation to prevent blood loss by enhancing coagulation
Massive loss of blood can occur upon trauma, surgery, childbirth, disseminated intravascular coagulation, gastrointestinal bleeding, etc. Recent studies have shown that urgent transfusion of regular plasma fails to stop massive bleeding, while other treatments are less efficient and result in increased mortality risk. The EU-funded ClearPlasma project is developing an innovative filtration system which modifies human plasma and improves the treatment of massive bleeding and bleeding disorders. The filtration extracts plasminogen, a critical protein component responsible for dissolving blood clots, enhancing coagulation and improving haemostasis, which significantly reduces bleeding. ClearPlasma is a disposable filter that can be incorporated in current clinical practices using apheresis systems. Current phase 1 of the project advances the broad development plan.
Fields of science
Programme(s)
Funding Scheme
SME-1 - SME instrument phase 1
Coordinator
1600101 Nazareth
Israel
See on map